A detailed history of National Pension Service transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, National Pension Service holds 2,807,643 shares of GILD stock, worth $252 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,807,643
Previous 2,477,353 13.33%
Holding current value
$252 Million
Previous $170 Million 38.46%
% of portfolio
0.23%
Previous 0.2%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$66.59 - $83.99 $22 Million - $27.7 Million
330,290 Added 13.33%
2,807,643 $235 Million
Q2 2024

Aug 12, 2024

BUY
$63.15 - $72.88 $4.13 Million - $4.76 Million
65,342 Added 2.71%
2,477,353 $170 Million
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $3.81 Million - $4.64 Million
53,179 Added 2.25%
2,412,011 $177 Million
Q4 2023

Feb 06, 2024

BUY
$73.27 - $83.09 $3.83 Million - $4.34 Million
52,214 Added 2.26%
2,358,832 $191 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $4.05 Million - $4.42 Million
54,766 Added 2.43%
2,306,618 $173 Million
Q2 2023

Aug 15, 2023

BUY
$76.01 - $86.7 $4.96 Million - $5.66 Million
65,293 Added 2.99%
2,251,852 $174 Million
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $3.14 Million - $3.58 Million
40,639 Added 1.89%
2,186,559 $181 Million
Q4 2022

Feb 23, 2023

BUY
$62.32 - $89.47 $593,473 - $852,022
9,523 Added 0.45%
2,145,920 $184 Million
Q4 2022

Feb 17, 2023

BUY
$62.32 - $89.47 $593,473 - $852,022
9,523 Added 0.45%
2,145,920 $184 Million
Q3 2022

Feb 23, 2023

SELL
$59.54 - $68.01 $566,999 - $647,659
-9,523 Reduced 0.44%
2,136,397 $132 Million
Q3 2022

Nov 17, 2022

BUY
$59.54 - $68.01 $2.92 Million - $3.33 Million
49,010 Added 2.35%
2,136,397 $135 Million
Q2 2022

Aug 17, 2022

BUY
$57.72 - $65.01 $10.8 Million - $12.1 Million
186,246 Added 9.8%
2,087,387 $129 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $8.73 Million - $10.9 Million
150,798 Added 8.62%
1,901,141 $113 Million
Q4 2021

Feb 15, 2022

SELL
$64.88 - $73.64 $481,409 - $546,408
-7,420 Reduced 0.42%
1,750,343 $127 Million
Q3 2021

Nov 18, 2021

SELL
$67.69 - $73.03 $725,636 - $782,881
-10,720 Reduced 0.61%
1,757,763 $123 Million
Q2 2021

Aug 17, 2021

BUY
$63.47 - $69.35 $1.92 Million - $2.1 Million
30,240 Added 1.74%
1,768,483 $122 Million
Q1 2021

May 14, 2021

BUY
$60.0 - $68.46 $5.83 Million - $6.65 Million
97,084 Added 5.92%
1,738,243 $112 Million
Q4 2020

Feb 19, 2021

BUY
$56.65 - $64.55 $4.7 Million - $5.36 Million
82,993 Added 5.33%
1,641,159 $95.6 Million
Q2 2020

Aug 11, 2020

BUY
$72.34 - $84.0 $1.4 Million - $1.62 Million
19,317 Added 1.26%
1,558,166 $120 Million
Q1 2020

May 27, 2020

BUY
$62.63 - $80.22 $1.11 Million - $1.42 Million
17,737 Added 1.17%
1,538,849 $115 Million
Q4 2019

Feb 21, 2020

BUY
$61.62 - $67.78 $5.54 Million - $6.09 Million
89,862 Added 6.28%
1,521,112 $98.8 Million
Q3 2019

Nov 15, 2019

BUY
$62.51 - $69.0 $4.2 Million - $4.63 Million
67,156 Added 4.92%
1,431,250 $90.7 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $5.02 Million - $5.63 Million
81,166 Added 6.33%
1,364,094 $92.2 Million
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $2.95 Million - $3.31 Million
47,232 Added 3.82%
1,282,928 $83.4 Million
Q4 2018

Feb 15, 2019

BUY
$60.54 - $79.0 $4.59 Million - $5.99 Million
75,884 Added 6.54%
1,235,696 $82 Million
Q3 2018

Nov 15, 2018

BUY
$71.28 - $78.92 $432,812 - $479,202
6,072 Added 0.53%
1,159,812 $89.5 Million
Q2 2018

Aug 14, 2018

BUY
$64.88 - $75.68 $5.34 Million - $6.23 Million
82,294 Added 7.68%
1,153,740 $81.1 Million
Q1 2018

Apr 13, 2018

BUY
$72.84 - $88.8 $1.22 Million - $1.48 Million
16,714 Added 1.58%
1,071,446 $80.8 Million
Q4 2017

Jan 17, 2018

BUY
$71.15 - $83.52 $1.8 Million - $2.11 Million
25,241 Added 2.45%
1,054,732 $75.6 Million
Q3 2017

Oct 16, 2017

BUY
$72.11 - $85.47 $74.2 Million - $88 Million
1,029,491
1,029,491 $83.3 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.